文献速递细菌感染、耐药与抗菌药物

整合抗生素过敏检测项目对抗菌药物管理的多中心评估

Impact of an Integrated Antibiotic Allergy Testing Program on Antimicrobial Stewardship: A Multicenter Evaluation.
PubMed 文献 · Clin Infect Dis · 2017-01-01

该多中心研究在澳大利亚两家大型医院实施整合抗生素过敏检测与抗菌药物管理(AAT-AMS)项目,评估其对患者自报抗生素过敏标签(AAL)流行率、抗生素使用及处方适宜性的影响。结果显示,118例接受检测的患者中83%成功去除过敏标签,且窄谱青霉素、窄谱β-内酰胺类及适宜抗生素处方几率显著增加,受限抗生素处方几率降低。

要点

  • AAT-AMS项目使83%患者成功去除抗生素过敏标签。
  • 检测后窄谱青霉素处方几率增加(aOR 2.81,95%CI 1.45-5.42)。
  • 检测后适宜抗生素处方几率大幅增加(aOR 12.27,95%CI 5.00-30.09)。

核心结论

  • 整合AAT-AMS项目能有效去除抗生素过敏标签并改善抗生素使用及适宜性,支持将AAT常规纳入AMS项目。

研究设计与样本

  • 在澳大利亚两家大型医院于2015年5月开始的14个月期间实施AAT-AMS项目,纳入118例接受抗生素过敏检测的患者。

主要发现

  • 118例患者共报告226个AAL(平均1.91/患者),其中53.6%涉及至少一种青霉素类药物。
  • AAT-AMS使98例(83%)患者成功去除AAL,其中56%(55/98)所有AAL均被去除。
  • 检测后窄谱青霉素处方几率增加(aOR 2.81,95%CI 1.45-5.42),窄谱β-内酰胺类增加(aOR 3.54,95%CI 1.98-6.33)。

临床怎么用

  • 可将抗生素过敏检测整合到抗菌药物管理项目中,以去除不必要的过敏标签并促进窄谱、适宜抗生素的使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite the high prevalence of patient-reported antibiotic allergy (so-called antibiotic allergy labels [AALs]) and their impact on antibiotic prescribing, incorporation of antibiotic allergy testing (AAT) into antimicrobial stewardship (AMS) programs (AAT-AMS) is not widespread. We aimed to evaluate the impact of an AAT-AMS program on AAL prevalence, antibiotic usage, and appropriateness of prescribing. METHODS: AAT-AMS was implemented at two large Australian hospitals during a 14-month period beginning May 2015. Baseline demographics, AAL history, age-adjusted Charlson comorbidity index, infection history, and antibiotic usage for 12 months prior to testing (pre-AAT-AMS) and 3 months following testing (post-AAT-AMS) were recorded for each participant. Study outcomes included the proportion of patients who were "de-labeled" of their AAL, spectrum of antibiotic courses pre- and post-AAT-AMS, and antibiotic appropriateness (using standard definitions). RESULTS: From the 118 antibiotic allergy-tested patients, 226 AALs were reported (mean, 1.91/patient), with 53.6% involving 1 or more penicillin class drug. AAT-AMS allowed AAL de-labeling in 98 (83%) patients-56% (55/98) with all AALs removed. Post-AAT, prescribing of narrow-spectrum penicillins was more likely (adjusted odds ratio [aOR], 2.81, 95% confidence interval [CI], 1.45-5.42), as was narrow-spectrum β-lactams (aOR, 3.54; 95% CI, 1.98-6.33), and appropriate antibiotics (aOR, 12.27; 95% CI, 5.00-30.09); and less likely for restricted antibiotics (aOR, 0.16; 95% CI, .09-.29), after adjusting for indication, Charlson comorbidity index, and care setting. CONCLUSIONS: An integrated AAT-AMS program was effective in both de-labeling of AALs and promotion of improved antibiotic usage and appropriateness, supporting the routine incorporation of AAT into AMS programs.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Trubiano JA, Thursky KA, Stewardson AJ, et al. Impact of an Integrated Antibiotic Allergy Testing Program on Antimicrobial Stewardship: A Multicenter Evaluation. Clin Infect Dis. 2017. PMID: 28520865. doi:10.1093/cid/cix244

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。